Oncopeptides AB (publ) (FRA:OND)
Germany · Delayed Price · Currency is EUR 0.2800
-0.0135 (-4.60%)
At close: Jan 30, 2026
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of €76.1 million as of January 30, 2026. Its market cap has increased by 204.93% in one year.
Market Cap
76.10M
Enterprise Value
76.19M
Revenue
5.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.28
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 176.17M to 76.10M, a decrease of -56.80%. That is a compound annual growth rate of -8.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 76.10M | -37.21% |
| Dec 30, 2025 | 121.20M | 314.81% |
| Dec 30, 2024 | 29.22M | -55.05% |
| Dec 29, 2023 | 65.00M | -36.80% |
| Dec 30, 2022 | 102.86M | 66.56% |
| Dec 30, 2021 | 61.75M | -94.61% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SMG Hospitality SE | 86.25M |
| Meta Wolf AG | 81.72M |
| Path2 Hydrogen AG | 78.06M |
| CGRE AG | 77.40M |
| InnoTec TSS AG | 69.38M |
| audius SE | 67.91M |
| learnd SE | 60.67M |
| WASGAU Produktions & Handels AG | 59.40M |